15 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
transferred our processes to commercial CMOs based in the United States for production, labeling, packaging and distribution of our initial batches of clinical … . The FDCA, PHSA and their corresponding regulations govern, among other things, the testing, manufacturing, safety, efficacy, labeling, packaging
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
, including requirements related to the manufacturing processes, post-approval clinical data, labeling, packaging, distribution, adverse event reporting … that a labeling instruction is required in product packaging recommending that combination, we could be accused of, or held liable for, infringement
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
, packaging, distribution, adverse event reporting, storage, recordkeeping, export, import, advertising, marketing, and promotional activities … or a sublicense. In the event that a labeling instruction is required in product packaging recommending that combination, we could be accused of, or held liable
10-Q
enlwa6xcp ah4754a6
12 Nov 20
Quarterly report
8:01am
424B4
2znnun buq1i
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
tthdsf
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.17
6jeemii
11 Sep 20
IPO registration
4:49pm
DRS/A
swg wpeuk
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
4m9ek8s rk
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
8zp8a4f gxe8m7
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
EX-10.17
whuh rjzsujnn1hm9p0h
31 Oct 19
Draft registration statement
12:00am
DRS
h0lxz wvillhe
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next